Estramustine phosphate therapy in poorly differentiated carcinoma of the prostate

Edsmyr, F.; Esposti, P.L.; Andersson, L.

Scandinavian Journal of Urology and Nephrology. Supplementum 55: 139-142

1980


ISSN/ISBN: 0300-8886
PMID: 6938017
Document Number: 160431
Ninety patients with poorly differentiated prostatic carcinoma have been treated with Estramustine phosphate (Estracyt). Seventeen of them had clinically metastases and had had no previous therapy. Seventy-three were initially given oestrogens and/or irradiation. Objective response was observed in 59%. The best effect was seen in patients primarily untreated.

Document emailed within 1 workday
Secure & encrypted payments